TABLE 1.
Diseases | Model in vivo or in vitro | Downstream pathway | Biological functions | Potential effect on COI | References |
AD | Apoe4 mice | Foxo3a upregulates the expressions of autophagy and mitophagy | Foxo3a ameliorates neuroinflammation | ↑ | Sohn et al., 2021; Zhou et al., 2024 |
Aβ-stimulated neurons | Foxo3a upregulates expressions of bim, puma and caspases-3 | Foxo3a induces apoptosis of neurons | ↓ | Sanphui and Biswas, 2013; Akhter et al., 2014; Saha and Biswas, 2015 | |
Stroke | MCAO/R rats | Foxo3a alleviates mitochondrial oxidative damage through increasing MnSOD expression | Foxo3a inhibits neurological damage | ↑ | Xie et al., 2022 |
MCAO/R rats | Foxo3a suppressed the expressions of BRCC3 and NLRP3 | Foxo3a alleviates oxidative stress and neuroinflammatory responses | ↑ | Tan et al., 2024 | |
tMCAO rats | Foxo3a promotes the activity of CREB factor | Foxo3a attenuates neuroinflammatory responses | ↑ | Chen B. et al., 2023 | |
IBI | Ovariectomized female rats | High expression of Foxo3a is accompanied by high level of caspase-3 | Foxo3a induces apoptosis of neurons | ↓ | Jover-Mengual et al., 2010 |
Hypoxia-ischemia rats | Foxo3a upregulates the expressions of bim and caspase-3 | Foxo3a triggers apoptosis of neurons | ↓ | Li et al., 2009, 2013, 2017 | |
Cerebral I/R mice | Foxo3a promotes the ROS production | Foxo3a reduces apoptosis and excessive ERS | ↑ | Shi et al., 2019 | |
Cerebral I/R rats | Foxo3a suppressed the activation of nrf2/glutathione signaling pathway | Foxo3a potentially reduces neuronal survival | ↓ | Zaki et al., 2022 | |
Cerebral I/R rats | Foxo3a inhibits the activation of NF-κB signaling pathway | Foxo3a alleviates neuroinflammatory responses | ↑ | Tan et al., 2021 | |
OGD-stimulated neurons | Foxo3a upregulate the expression of bax, cleaved caspase 3, but reduces the level of bcl-2 | Foxo3a protect against neuronal cell injury | ↑ | Meng et al., 2022 | |
PA | Dopaminergic neuronal PC12 cells | Foxo3a activates the autophagy | No significant effect of Foxo3a on neuronal viability | Unknown | He et al., 2022 |
MPTP mice | Increased level of Foxo3a is accompanied by increased level of MnSOD/NQO1/HO-1, but decreased NF-κB pathway | Foxo3a potentially rescues the loss of dopaminergic neurons | ↑ | Leem et al., 2024 | |
MPTP mice | Foxo3a upregulate the expression of bim | Foxo3a inhibits the apoptosis of neuron | ↑ | Liu L. et al., 2014 | |
6-hydroxy dopamine-treated cells and rats | Foxo3a promotes the expression of puma and FasL | Foxo3a triggers neuron death | ↓ | Sanphui et al., 2020; Bhattacharyya et al., 2023 | |
TBI | Mice treated with weight drop | Acetylation of Foxo3a increased the level of bim | Acetylation of Foxo3a triggers apoptosis of neuron | ↓ | Xu et al., 2024 |
Mice struck by convex tip | Foxo3a transcriptionally upregulates AQP4 | Foxo3a leads to cytotoxic edema | ↓ | Kapoor et al., 2013 | |
Mice treated with weight drop | Foxo3a activates autophagy | Foxo3a initiates neuronal damage in the hippocampus | ↓ | Sun et al., 2018 |
MCAO/R, middle cerebral artery occlusion/reperfusion, tMCAO, transient middle cerebral artery occlusion, IBI, ischemic brain injury, OGD, oxygen-glucose deprivation, MPTP, methyl-4-phenyl-1,2,3,6-tetrahydropyridine, AQP4, Aquaporin 4. “↑” represents promotion of COI, “↓” represents inhibition of COI.